Podcasts

Oncology Peer Review On-The-Go: Value of Geriatric Assessment in Patients With Genitourinary Carcinomas
November 22, 2021

Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.

Oncology Peer Review On-The-Go: Germline Testing in Prostate Cancer: When and Who to Test
November 08, 2021

The recent episode of the "Oncology Peer Review On-The-Go" podcast features Alexandra Sokolova, MD, discussing her article on germline testing and NCCN guidelines for patients with prostate cancer.

OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
November 02, 2021

Connie Batlevi, MD, PhD, detailed important updates in therapies for relapsed/refractory follicular lymphoma in this episode of CancerNetwork’s® podcast.

Oncology Peer Review On-The-Go: First-Line Therapeutic Options in Small Cell Lung Cancer
November 01, 2021

In the first episode of a 4-part series, CancerNetwork® spoke with Wade Iams, MD, about the various first-line treat options that are available for patients with small cell lung cancer.

Oncology Peer Review On-The-Go: Debra Patt, MD, PhD, MBA, on Telehealth in Cancer Care
October 26, 2021

CancerNetwork® spoke with Debra Patt, MD, PhD, MBA, about the role of telehealth in caring for patients with cancer during the COVID-19 pandemic and beyond.

Between the Lines Podcast: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
October 19, 2021

Brian Helfand, MD, PhD, and Steven Finkelstein, MD, FACRO, discussed the phase 2/3 EMPIRE-1 trial focusing on 18F-fluciclovine PET/CT imaging versus conventional imaging to guide postprostatectomy salvage radiotherapy for patients with prostate cancer.

Oncology Peer Review On-The-Go: Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer
October 12, 2021

On this week’s podcast, Jun Gong, MD, spoke with CancerNetwork® about the potential role of plasma glutamine as a biomarker for patients with localized prostate cancer.

Oncology Peer Review On-The-Go: ScaleReady’s Work to Make Cell and Gene Therapy Practical and Viable
September 28, 2021

CancerNetwork speaks with Josh Ludwig on its latest podcast to discuss ScaleReady’s plans to make cell and gene therapy more practical and viable moving forward.

Oncology Peer Review On-The-Go: Inside the Advancing Inclusive Research Site Alliance for Clinical Trial Diversity
September 14, 2021

The latest episode of CancerNetwork®’s podcast examines an initiative to diversify patient populations in oncology clinical trials and increase accessibility to these opportunities.

Oncology Peer Review On-The-Go: Two Experts Review Important R/R DLBCL Treatment Decisions and Data
August 30, 2021

Gilles Salles, MD, PhD, and Kami Maddocks, MD, discuss relapsed/refractory diffuse large B-cell lymphoma therapeutic options and important data from the L-MIND trial.